NeuroVanda is Singapore-based biotech developing transformational therapies for neurodegenerative diseases. We achieve this by leveraging deep insights in disease mechanism, employing disease-relevant models and pairing the best-suited therapeutic modalities with the most pertinent targets
Our team consists of world renowned scientific founders from University of Pennsylvania, World Cornell Medicine and University of California, San Francisco. NeuroVanda is leveraging translational models that have been developed over decades in the labs of our scientific founders and are guided by the deep expertise to further establish pathophysiologically relevant models. The NeuroVanda team also comprises of experienced drug hunters who have deep expertise in developing novel modalities such as protein degraders to tackle the most pertinent of targets.
Company Details
- Employees
- 5
- Address
- 1 N Buona Vista Link, Singapore,139691,singapore
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Singapore
Neurovanda Therapeutics Questions
Neurovanda Therapeutics's LinkedIn profile is https://sg.linkedin.com/company/neurovanda-therapeutics
Neurovanda Therapeutics has
5 employees.
View email and phone details for 5
employees at Neurovanda Therapeutics.
Neurovanda Therapeutics's industry is
Biotechnology Research
Neurovanda Therapeutics's top competitors are
Biotech Connection Singapore,
Lerna Biopharma,
Axcynsis Therapeutics,
Nuevocor,
Trinity Innovation Bioventure Singapore,
Carmine Therapeutics,
Tessa Therapeutics Ltd,
Msd,
Ligature Therapeutics,
Lucence.
Neurovanda Therapeutics's categories are Biotechnology Research
